SCHEMBL16634741

SCHEMBL16634741

O=C(O)c1ccc(Nc2ccc(COC3CCCCO3)cc2[N+](=O)[O-])cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.55
HCAR3 P49019 5/20 0.53
MAPT P10636 3/20 0.50
AKR1C3 P42330 2/20 0.50
AKR1C2 P52895 2/20 0.50
MEN1 O00255 5/20 0.48
CREBBP Q92793 1/20 0.47
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
AKR1B10 O60218 1/20 0.43
AKR1B1 P15121 1/20 0.43
AKR1C4 P17516 1/20 0.43
AKR1C1 Q04828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16634739 1.00 KMT2A (0.55) KMT2AHCAR3MAPTAKR1C3AKR1C2
SCHEMBL16634625 0.89 HCAR3 (0.52) KMT2AHCAR3MAPTAKR1C3AKR1C2
SCHEMBL16634623 0.89 HCAR3 (0.52) KMT2AHCAR3MAPTAKR1C3AKR1C2
SCHEMBL16634584 0.85 CREBBP (0.49) KMT2AHCAR3MAPTAKR1C3AKR1C2
SCHEMBL20985428 0.80 HCAR3 (0.49) KMT2AHCAR3MAPTMEN1LMNA
SCHEMBL20985427 0.80 HCAR3 (0.49) KMT2AHCAR3MAPTMEN1LMNA
SCHEMBL14852475 0.78 CREBBP (0.41) KMT2AHCAR3MAPTAKR1C3AKR1C2
SCHEMBL3811958 0.78 KMT2A (0.64) KMT2AMEN1CREBBPNPC1ALDH1A1
SCHEMBL20985435 0.76 ALDH1A1 (0.38) KMT2AHCAR3MAPTMEN1CREBBP
SCHEMBL3078394 0.76 KMT2A (0.45) KMT2AHCAR3MAPTMEN1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed